Clinical trial
Tuberculosis in HIV Infected Patients in Uganda
NCT00057421 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00057421 |
|---|---|
| Title | Tuberculosis in HIV Infected Patients in Uganda |
| Official title | Impact of Tuberculosis on HIV Infection in Uganda |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tuberculosis, HIV Infections |
| Intervention type | Drug |
| Interventions | prednisolone |
| Enrollment | 190 |
| Start date | Nov 1, 1998 |
| Completion | Sep 1, 2002 |
| First posted | Apr 3, 2003 |
| Last update posted | Sep 18, 2007 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: